Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03618628 · ClinicalTrials.gov registry record · NA
Peak Plantar Pressures While Wearing a Carbon Fiber Off Loading Orthoses
A NA study of Diabetes Mellitus and Peripheral Neuropathy, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT03618628: Completed NA study of Diabetes Mellitus and Peripheral Neuropathy, sponsored by Washington University School of Medicine.
NCT03618628 is a NA study of Diabetes Mellitus and Peripheral Neuropathy that has completed, run by Washington University School of Medicine. The registered enrollment target is 3 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03618628, a NA study of Diabetes Mellitus and Peripheral Neuropathy, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the ability of carbon fiber off loading orthoses to reduce plantar pressure while providing an augmented plantarflexor power to improve walking and function. Results of this study could lead to increased use of carbon fiber off loading orthoses for patients with diabetes, peripheral neuropathy, and foot wounds as a way augmenting wound healing and preventing future recurrences of wounds.
Primary Outcome
Plantar pressure during walking while the participant wears the brace fabricated based on the finite element (FE) model compared to 1) the brace fabricated based on current clinical standards and 2) barefoot.
Conditions Studied
Interventions
- DEVICE Carbon Fiber Off Loading Orthosis (CFO)
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-05-24 |
| Est. Completion | 2018-04-12 |
| Phase | NA |
What the finished NCT03618628 record still lists
NCT03618628 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Carbon Fiber Off Loading Orthosis (CFO) is the first listed.
NCT03618628 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03618628 about?
NCT03618628 is a clinical study titled "Peak Plantar Pressures While Wearing a Carbon Fiber Off Loading Orthoses". The purpose of this study is to determine the ability of carbon fiber off loading orthoses to reduce plantar pressure while providing an augmented plantarflexor power to improve walking and function. Results of this study could lead to increased use of carbon fiber off loading orthoses for patients ...
What is the current status of trial NCT03618628?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2016-05-24. Estimated completion is 2018-04-12.
What conditions does trial NCT03618628 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Peripheral Neuropathy, Orthotic Device.
What interventions are being tested in trial NCT03618628?
The interventions under investigation include: Carbon Fiber Off Loading Orthosis (CFO) (DEVICE).
Who is sponsoring clinical trial NCT03618628?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03618628 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03618628's enrollment target sits among peer trials
3 208th of 208 the lowest of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI